Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Pediatric Brain Tumor Consortium
NYU Langone Health
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center